120 related articles for article (PubMed ID: 7910322)
1. Growth hormone treatment in growth-retarded adolescents after renal transplant.
Hokken-Koelega AC; Stijnen T; de Ridder MA; de Muinck Keizer-Schrama SM; Wolff ED; de Jong MC; Donckerwolcke RA; Groothoff JW; Blum WF; Drop SL
Lancet; 1994 May; 343(8909):1313-7. PubMed ID: 7910322
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
[TBL] [Abstract][Full Text] [Related]
3. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
4. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
5. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
[TBL] [Abstract][Full Text] [Related]
7. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases.
Hokken-Koelega AC; Saenger P; Cappa M; Greggio N;
J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():945-52. PubMed ID: 11529400
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone administration in pediatric renal allograft recipients.
Bartosh S; Kaiser B; Rezvani I; Polinsky M; Schulman S; Palmer J; Baluarte HJ
Pediatr Nephrol; 1992 Jan; 6(1):68-73. PubMed ID: 1536744
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and the kidney: the use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency.
Fine RN
J Am Soc Nephrol; 1991 Apr; 1(10):1136-45. PubMed ID: 1768809
[TBL] [Abstract][Full Text] [Related]
10. Body proportions before and during growth hormone therapy in children with chronic renal failure.
de Graaff LC; Mulder PG; Hokken-Koelega AC
Pediatr Nephrol; 2003 Jul; 18(7):679-84. PubMed ID: 12734746
[TBL] [Abstract][Full Text] [Related]
11. Effects of two years of growth hormone treatment in short children with renal disease. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Tönshoff B; Dietz M; Haffner D; Tönshoff C; Stöver B; Mehls O
Acta Paediatr Scand Suppl; 1991; 379():33-41. PubMed ID: 1815458
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of growth hormone treatment in GH-deficient adults.
Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
[TBL] [Abstract][Full Text] [Related]
13. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment in children before and after renal transplantation.
Hokken-Koelega AC
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():359-64. PubMed ID: 8887181
[TBL] [Abstract][Full Text] [Related]
16. [Chronic kidney insufficiency: results of treatment with growth hormone].
Hokken-Koelega AC
Tijdschr Kindergeneeskd; 1992 Oct; 60(5):177-82. PubMed ID: 1448808
[TBL] [Abstract][Full Text] [Related]
17. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
[TBL] [Abstract][Full Text] [Related]
18. [Chronic renal insufficiency and growth].
Pasqualini T; Ferraris J
Medicina (B Aires); 2003; 63(6):731-6. PubMed ID: 14719318
[TBL] [Abstract][Full Text] [Related]
19. [Growth hormone therapy in prepubertal children with chronic renal insufficiency].
Kost'álová L; Misíková Z; Furková K; Lebl J; Simková E; Krásnicanová H
Cas Lek Cesk; 1995 Dec; 134(24):788-90. PubMed ID: 8599822
[TBL] [Abstract][Full Text] [Related]
20. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients.
Ingulli E; Singh A; Moazami S; Tejani A
Kidney Int Suppl; 1993 Oct; 43():S65-70. PubMed ID: 8246373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
